How Often Should You Get Allergy Shots? Evidence-Based Recommendations
Evidence-based guidelines recommend allergy shots 1-2 times per week during the 3-6 month build-up phase, then monthly during the 3-5 year maintenance phase. Twice-weekly build-up reaches maintenance approximately 40% faster than once-weekly with equivalent safety. Monthly maintenance is non-inferior to biweekly for stable patients. Completing 3-5 years produces disease-modifying benefits lasting 3-12 years after stopping — the optimal duration is 3 years minimum, 5 years for maximum benefit.
6 peer-reviewed sources
The evidence-based recommendation is 1-2 allergy shots per week during build-up and one shot monthly during maintenance for 3-5 years total. Twice-weekly build-up gets you to maintenance faster; monthly maintenance is as effective as biweekly for most stable patients.
What the Evidence Says About the Optimal Allergy Shot Frequency
The question of how often allergy shots should be given is answered by a specific body of clinical evidence — practice parameters, controlled trials, and systematic reviews — not by anecdote or individual preference. Here is what the evidence actually says.
Build-up frequency: The AAAAI/ACAAI 2011 Practice Parameters (Cox et al.) recommend 1-2 injections per week during build-up, rated as Level B evidence. Twice-weekly build-up reaches the maintenance dose approximately 40% faster than once-weekly across multiple retrospective studies, with comparable systemic reaction rates. There is no significant evidence that twice-weekly produces better long-term outcomes — the benefit is speed, not efficacy.
Maintenance frequency: Monthly maintenance (every 4 weeks) is the consensus standard across AAAAI, ACAAI, WAO, and EAACI guidelines. Nelson (2014) demonstrated that monthly maintenance is non-inferior to biweekly for patients who have been stable on maintenance for more than one year. The WAO 2014 Position Paper endorses 4-week intervals as standard, with 2-week intervals reserved for patients with suboptimal response.
Treatment duration: Durham et al. (NEJM 1999) established the landmark evidence for duration — 3 years minimum for disease modification, with benefits lasting 3 years post-discontinuation. Subsequent research supports 5 years for maximum benefit, particularly for patients with severe or multi-sensitized disease.
Sub-optimal frequency consequences: Roberts et al. (JACI 2006) found that less-than-monthly maintenance during the first year was associated with reduced long-term benefit — the only frequency level where evidence directly shows efficacy loss.
Before starting immunotherapy, knowing your full allergen profile ensures the treatment covers the right triggers. Services like Curex provide at-home testing for 40+ allergens, giving your allergist the baseline IgE data needed to monitor treatment response.
Evidence-based optimal: 1-2x/week build-up, monthly maintenance, 3-5 year duration. Monthly is non-inferior to biweekly for stable patients. Less than monthly in year one reduces benefit. Completing 5 years vs. 3 years produces better long-term disease modification.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
What the Evidence Shows About Optimal Frequency and Outcomes
The efficacy data for allergy shots comes primarily from randomized controlled trials and Cochrane systematic reviews. The frequency recommendations are supported by these evidence levels — understanding which recommendations have strong trial support vs. expert consensus helps patients make informed decisions about their schedules.
Success Rate by Duration
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youEvidence-Based Allergy Shots, Now Without the Clinic Schedule
For patients seeking guideline-backed immunotherapy without traveling for every dose, the same subcutaneous immunotherapy can be self-administered at home under allergist supervision — the build-up and maintenance frequency the evidence supports stays identical.
| Treatment | Efficacy | Duration | Cost (5yr) | Convenience | Safety |
|---|---|---|---|---|---|
At-Home Allergy Shots (SCIT)Best | Disease-modifying; 33-85% symptom reduction; benefits last 3-12 years after stopping | 3-5 years then discontinue | $3,000-$10,000+ | Self-administered at home with Curex; evidence-based 1-2x/week build-up then monthly maintenance; brief self-observation after each dose | 0.1-0.2% systemic reaction rate per injection; first dose and every dose change supervised live over Zoom, with a prescribed epinephrine auto-injector confirmed on hand |
Sublingual Drops (SLIT) | Comparable disease modification for many allergens; significant symptom reduction in Cochrane reviews | 3-5 years then discontinue | $2,340-$3,500 | Daily drops at home; zero clinic visits after initial consult; 30 seconds per dose | Local oral reactions most common; systemic reactions rare; no post-dose observation required |
- Efficacy
- Disease-modifying; 33-85% symptom reduction; benefits last 3-12 years after stopping
- Duration
- 3-5 years then discontinue
- Cost (5yr)
- $3,000-$10,000+
- Convenience
- Self-administered at home with Curex; evidence-based 1-2x/week build-up then monthly maintenance; brief self-observation after each dose
- Safety
- 0.1-0.2% systemic reaction rate per injection; first dose and every dose change supervised live over Zoom, with a prescribed epinephrine auto-injector confirmed on hand
- Efficacy
- Comparable disease modification for many allergens; significant symptom reduction in Cochrane reviews
- Duration
- 3-5 years then discontinue
- Cost (5yr)
- $2,340-$3,500
- Convenience
- Daily drops at home; zero clinic visits after initial consult; 30 seconds per dose
- Safety
- Local oral reactions most common; systemic reactions rare; no post-dose observation required
For patients who want guideline-supported allergy shots without driving to a clinic for build-up, Curex prescribes a personalized SCIT serum for $129/month all-inclusive — one weekly shot at home on the same evidence-based escalation schedule, with your first dose and dose changes supervised live over Zoom by a board-certified allergist.
See if at-home shots are right for youFrequently asked questions
What frequency of allergy shots does the evidence recommend?
The evidence from the AAAAI/ACAAI 2011 Practice Parameters (Cox et al.) recommends 1-2 allergy shots per week during build-up (Level B evidence) and every 2-4 weeks during maintenance (Level C/expert consensus). Twice-weekly build-up reaches the maintenance dose approximately 40% faster than once-weekly, with equivalent long-term outcomes. Monthly maintenance (every 4 weeks) is the standard endorsed by WAO, AAAAI, and EAACI guidelines, with Nelson (2014) confirming non-inferiority compared to biweekly for stable patients. The key evidence gap: no large-scale RCTs have directly compared 2-week vs. 3-week vs. 4-week maintenance intervals — the monthly recommendation is consensus rather than experimental.
Is twice-weekly build-up better than once-weekly?
Twice-weekly build-up reaches the maintenance dose approximately 40% faster than once-weekly — 3-4 months vs. 5-7 months — based on multiple retrospective studies. However, long-term outcomes at 1, 3, and 5 years are equivalent between once-weekly and twice-weekly build-up schedules. The recommendation from Cox et al. (JACI 2011) allows both, with the choice based on patient scheduling capacity and preference for faster vs. slower progression. Twice-weekly does not carry significantly higher systemic reaction rates compared to once-weekly in conventional protocols. If your schedule can accommodate twice-weekly visits, you will reach the symptomatic improvement phase faster — but your long-term outcomes will be the same either way.
Is monthly maintenance as effective as biweekly maintenance?
Yes — for stable patients who have been on maintenance for at least one year, monthly maintenance (every 4 weeks) is non-inferior to biweekly maintenance (every 2 weeks). Nelson (2014) demonstrated this in a controlled study, and the WAO 2014 Position Paper endorses monthly as the standard interval. Biweekly maintenance is recommended for patients who show suboptimal symptom control on monthly dosing or who have severe disease requiring tighter allergen tolerance maintenance. For the majority of stable adult patients, the evidence supports monthly maintenance as the optimal frequency — balancing clinical effectiveness with practical scheduling burden. Pediatric allergists sometimes prefer biweekly during the first year of maintenance for closer monitoring, independent of efficacy differences.
How long should you continue allergy shots for the best results?
The evidence-based recommendation is 3-5 years of allergy shots for optimal disease modification. Durham et al. (NEJM 1999) demonstrated that 3 years of grass pollen SCIT produced lasting benefits for at least 3 years post-discontinuation. The WHO Position Paper (Canonica, WAO 2014) recommends a minimum of 3 years regardless of protocol. Five-year treatment produces superior disease modification: a 5-year grass pollen SCIT study showed significantly greater long-term benefit than 3-year treatment, and the PAT study (Jacobsen et al., Allergy 2007) found that 3 years of childhood SCIT prevented asthma development over 7 years of follow-up. For patients with severe polysensitization or asthma, 5 years is the preferred endpoint.
What happens if you get allergy shots less often than recommended?
Getting allergy shots less frequently than recommended — particularly less than monthly during the first year of maintenance — is associated with reduced disease modification outcomes. Roberts et al. (JACI 2006) found that suboptimal maintenance frequency (less than monthly) was associated with lower long-term symptom reduction compared to consistent monthly dosing. For build-up injections, gaps of more than 7 days require dose reductions per Cox et al. (JACI 2011), extending the build-up timeline and potentially reducing the cumulative allergen dose delivered before maintenance. The concept from Creticos (JACI 1996) that cumulative allergen dose drives outcomes means that consistently skipping or delaying doses directly reduces the total allergen exposure delivered, which correlates with reduced long-term benefit.
Do European guidelines recommend the same allergy shot frequency as US guidelines?
European guidelines (EAACI 2018) recommend similar build-up frequencies to US guidelines: 1-2 injections per week during conventional build-up, transitioning to every 4-6 weeks during maintenance. Minor differences exist: European guidelines are somewhat more broadly supportive of cluster protocols compared to US practice, and some European centers use every-4-6 week maintenance intervals routinely for stable patients. The WAO Position Paper (Canonica 2014) synthesizes global consensus, recommending the same 1-2x/week build-up and 2-4 week maintenance interval endorsed by AAAAI and ACAAI. The minimum treatment duration recommendation — 3 years — is consistent across all major international guidelines.
What evidence level supports the allergy shot frequency recommendations?
The evidence levels supporting allergy shot frequency recommendations vary by recommendation. Build-up frequency of 1-2x/week is Level B evidence per Cox et al. (JACI 2011) — supported by controlled studies. The maintenance interval of every 2-4 weeks is Level C (expert consensus) — not supported by direct comparative RCTs between specific intervals. The treatment duration recommendation of 3-5 years is Level A evidence for the minimum 3-year threshold, based on the landmark Durham et al. (NEJM 1999) study and subsequent confirmatory trials. The recommendation that monthly is equivalent to biweekly for stable patients comes from a single well-designed controlled study (Nelson 2014). Patients should understand that some frequency recommendations reflect expert consensus rather than large RCT data.
Related Articles
How Long Do Allergy Shots Take? Trial vs Reality | Curex
How long do allergy shots take to work? Trials show 12-month benefit, but only 23% complete 3 years. Real-world vs clinical data guide.
Read moreAllergy Shots: The Complete Patient Guide to SCIT | Curex
Allergy shots (SCIT) are the only FDA-recognized disease-modifying allergy treatment. Learn who qualifies, how they work, and what alternatives exist.
Read moreWhat Is Allergy Shots? Quick Definition and How It Works
What is allergy shots? SCIT trains your immune system to tolerate allergens over 3-5 years. 85-90% of patients see significant improvement.
Read moreAllergy Shot Side Effects: Per-Injection Timeline | Curex
What happens after each allergy shot? A minute-by-minute timeline from the 30-min wait to 48-hour local reactions, with safety thresholds and real data.
Read moreAllergy Immunotherapy Guide: All Options Compared | Curex
Allergy immunotherapy covers shots, tablets, drops, and OIT. Compare SCIT vs SLIT on efficacy, safety, cost, and FDA status to choose the right route.
Read moreAllergy Shots: Complete SCIT Guide for Patients | Curex
Allergy shots (SCIT) reduce symptoms by 33-85% over 3-5 years. Learn how they work, what they cost, and who qualifies for this disease-modifying treatment.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.